A Next-Gen Liquid Biopsy Detects Signs of Breast Cancer in Early-Stages, USC Study Finds
Scientists found indications that a liquid biopsy could determine whether a patient has breast cancer at its early stage.
Category: Breast
Breast
Latest
Breast
Latest
AI Software Spots Breast Cancer Metastases in Lymph Nodes
Paige, has launched its Paige Breast Lymph Node, an AI software that helps detect if breast cancer has metastasized to lymph nodes.
Breast
Latest
Cerebrospinal Fluid Assay Identifies Mutations in Breast Cancer Patients
A new assay can identify HER2 and other tumor alterations in the cerebrospinal fluid of patients with breast cancer and leptomeningeal disease (LMD).
AI-based Method Improves Breast Cancer Prediction
Researchers in Sweden have developed a new artificial intelligence analyzer that may help predict breast cancer.
Read More
More than BRCA: The other life-threatening breast cancer gene mutation to be aware of
Undergoing genetic testing Keri Forsythe-Stephens, learned she had a mutation of the gene, CHEK2, making her more susceptible to breast cancer.
Read More
OneOncology: NGS Testing Is Backbone of Personalized Treatments
OneOncology and Genentech presented data at a symposium that examined genomic profiling and biomarker testing patterns in community oncology centers.
Read More
Photoacoustic Finder Helps Diagnose Metastatic Cancer
A research team has developed a handheld photoacoustic finder that can help diagnose cancer without radiation exposure.
Read More
Liquid Biopsy Screening May Detect Breast Cancer Earlier
AnchorDx has developed a new early breast cancer diagnostic model based on circulating cell-free DNA-based (cfDNA) methylation patterns.
Read More
Breast Cancer Assay Aims to Distinguish Cancer from Benign Tumors
A novel laboratory test in development by researchers may be used to help quickly distinguish breast cancer from benign disease.
Read More
This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
As part of their regular breast health screening, many women are routinely tested for the BRCA1 and BRCA2 mutations. They should also be tested for PALB2.
Read More
Women of all Ancestries Can Now Assess Their Genetic Breast Cancer Risk
Myriad Genetics, Inc., has launched a new version of its MyRisk Hereditary Cancer Test. Women of all ancestries can assess breast cancer risk.
Read More
Mayo Clinic Research Suggests Women Over 65 Be Offered Hereditary Cancer Genetic Testing
The study results suggest that perhaps all women with breast cancer, including those diagnosed over age 65, should be offered hereditary breast cancer testing.
Read More
Black and White Women Have Same Mutations Linked to Breast Cancer Risk
“The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” says first author Susan Domchek, MD.
Read More
New Biosensor Developed to Aid Early Diagnosis of Breast Cancer
The mesoporous biosensor developed to detect breast cancer is easy to use, low cost, and provides results in a very short time—between 30 and 60 minutes—from a sample of the patient’s plasma.
Read MoreWebinar: Detecting PI3K Signaling Pathway Mutations
Resistance to breast cancer therapy and disease progression may result from activation of the PI3K pathway.
Read More
Biomarker Assay Identifies DCIS Patients at Increased Risk for Breast Cancer-Specific Death
The DCISionRT Decision Score from PreludeDx was significantly associated with breast cancer mortality while clinicopathologic factors were not.
Read More
Breast Cancer HER2 Control Cell Line Array
This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER, and PR expression, validated by the Ventana system.
Read More
Mayo Clinic Researchers Develop Test to Measure Effect of Breast Cancer Gene Variants
The lead researcher says the results will have a positive effect on patient care because patients will know whether breast cancer VUS are benign or pathogenic.
Read More